1,3-Benzodioxolyl-N-ethylbutanamine

1,3-Benzodioxolyl-<i>N</i>-ethylbutanamine

1,3-Benzodioxolyl-N-ethylbutanamine

Entactogen, stimulant, and psychedelic designer drug


Ethylbenzodioxolylbutanamine (EBDB; Ethyl-J) is a lesser-known entactogen, stimulant, and psychedelic. It is the N-ethyl analogue of benzodioxylbutanamine (BDB; "J"), and also the α-ethyl analogue of methylenedioxyethylamphetamine (MDEA; "Eve").

Quick Facts Names, Identifiers ...

EBDB was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage consumed was 90 mg, and the duration is unknown.[1] EBDB produced few to no effects at the dosage range tested in PiHKAL, but at higher doses of several hundred milligrams it produces euphoric effects similar to those of methylbenzodioxylbutanamine (MBDB; "Eden", "Methyl-J"), although milder and shorter lasting.[citation needed]

Very little data exists about the pharmacological properties, metabolism, and toxicity of EBDB.

See also


References



Share this article:

This article uses material from the Wikipedia article 1,3-Benzodioxolyl-N-ethylbutanamine, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.